GCC Generic Injectables Market Report 2018: Industry Trends, Growth, Share, Size, Region and Forecast Till 2023

1. GCC Generic Injectables Market Report | Industry Trends and Forecast by 2023 Copyright © IMARC Service Pvt Ltd. All Rights Reserved

2. About IMARC Group Report Description IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description GCC Generic Injectables Market Report By Container Type (Vials, Prefilled Syringes, Ampoules, Premix and Others), Therapeutic Area (Oncology, Anaesthesia, Anti-infectives , Cardiovascular, Parenteral Nutrition and Others), Distribution Channel, Region The GCC generic injectables market has witnessed a robust growth over the past several years. The growing geriatric population and prevalence of chronic diseases along with rising government support are escalating the demand for generic injectables in the region. Market Overview: According to the latest report by IMARC Group, titled “GCC Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the GCC generic injectables market reached a value of US$ 392 Million in 2017. Generic injectables refer to drugs that have the same active ingredients, strength, dosage and route of administration as that of branded injectables. In the GCC countries, the demand for injectables is rising as they aim to increase patient compliance without compromising with the effectiveness of the treatment. Moreover, the lower cost of these injectables as compared to their branded equivalents helps in providing substantial savings for both the patients and healthcare providers.

4. Report Description and Highlights Report Description • Market Trends: • In the GCC countries, the proportion of people aged 65 or more is predicted to increase due to declining fertility rates and increasing life expectancy. As a result of the subsequent increase in the prevalence of geriatric diseases and conditions, the sales of generic injectables in the region are expected to increase. Further, the pharmaceutical industry in Saudi Arabia, UAE, Kuwait and Qatar is at a nascent stage. In line with this, the governments of these countries are focusing on encouraging the domestic manufacturing and supply of these drugs to reduce costs. For instance, the Ministry of Health in the UAE is working on increasing the number of generic drug manufacturing facilities in the country. Apart from this, several domestic generic injectable manufacturers, particularly in Saudi Arabia, are collaborating with global and regional pharma players to expand their manufacturing capacity. Looking forward, the market is projected to reach a value of US$ 776 Million by 2023, expanding at a CAGR of 12.1% during 2018-2023. • GCC Generic Injectables Market Segmentation: • Market Segmentation by Container Type • Vials • For more information, click here: https://www.imarcgroup.com/gcc-generic-injectables-market

5. Market Forecast Sample Figure: GCC: Generic Injectables Market Forecast: Sales Value (in Million US$), 2018-2023

6. Market Segmentation Report Description • Prefilled Syringes • Ampoules • Premix • Others • On the basis of container type, the market has been segmented as vials, prefilled syringes, ampoules and premix. Amongst these, vials are the preferred container • Market Segmentation by Therapeutic Area • Oncology • Anaesthesia • Anti-infectives • Cardiovascular • Parenteral Nutrition • Others • Based on the therapeutic area, oncology dominates the market, holding the largest share. Other major segments include anesthesia, anti-infectives, cardiovascular and parenteral nutrition. • Request for a sample report: https://www.imarcgroup.com/request?type=report&id=1005&flag=B

7. Market Segmentation Report Description • Market Segmentation by Region • Saudi Arabia • UAE • Kuwait • Qatar • Oman • Bahrain • Region-wise, Saudi Arabia enjoys the leading position in the GCC generic injectables market. Saudi Arabia is followed by the UAE, Kuwait, Qatar, Oman and Bahrain. • Market Segmentation by Distribution Channel • Hospitals • Clinics • Retail Pharmacy Stores • The market has also been divided on the basis of distribution channels into hospitals, clinics and retail pharmacy stores. Generic injectables are majorly distributed through hospitals.

8. Market Segmentation Report Description • Competitive Landscape: • The competitive landscape of the GCC generic injectables market has also been analyzed with the profiles of the key players. • In case you have a very specific customized or specific niche needs, we can work around the scope of work and assist you with the tailor made solution. The topics covered could be technology, markets, competition, pricing trends, P&L analysis, cost analysis, price bench marking or it could also be supplementing you with the weekly or fortnight reports.

9. Team Profile Our Team Comes From Some of the Top Universities Globally. Team Profile 60% Engineering and Science 5% Others 35% Business Studies Average Experience of 7+ Years Over 2000 Independent Consultants from different sectors.

10. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

11. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

12. Report Description and Highlights Report Description © 2018 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

13. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: • TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com